Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.055    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

DIVIDEND DECLARATION & DIV TARGET '25(Replacement)

27 Jan 2025 18:15

RNS Number : 8572U
CVC Income & Growth Limited
27 January 2025
 

27 January 2025

 

CVC Income & Growth Limited

 

DIVIDEND DECLARATION & ANNUAL DIVIDEND TARGET '25 (Replacement)

 

The following amendment has been made to the announcement released on 24 January 2025 at 12:53hrs (RNS No. 6613U). In the second paragraph, the quarterly interim dividend per ordinary Euro share has been corrected from 2.486c to 2.0486c. All other details remain unchanged. The full amended text is shown below.

Dividend Declaration and

Annual Dividend Targets for financial year 2025

The information contained within this announcement constitutes inside information.

The Board of Directors of the Company has declared a quarterly interim dividend of 3.3038p per ordinary Sterling Share and 2.0486c per ordinary Euro Share.

These amounts reflect an uplift to the previously indicated quarterly dividend of 2.0625p per Sterling ordinary share and 1.8125c per Euro ordinary share announced by the Company on 30 January 2024.

The ex-dividend date will be 6 February 2025, with the dividends payable on 28 February 2025.

The Board of Directors, in conjunction with the Investment Vehicle Manager, has also completed its periodic review of the Company's annual dividend targets. As a consequence, the Company's annual dividend targets are 9.25p per ordinary Sterling Share (an increase of 1p above 2024) and 7.25c per ordinary Euro Share (unchanged from 2024) with from the first 2025 quarterly interim dividend. This means that the Company's quarterly dividends will be 2.3125p per Sterling Share and 1.8125c per Euro Share, including the Company's first quarter 2025 dividends, payable in the second quarter of 2025.

The Chairman of the Company, Robert Kirkby commented: "The Board of Directors continues to give detailed consideration, not only to the current cash yield of the Investment Vehicle's underlying portfolio by principal reference to its weighted average coupon, but also to market conditions including future trends in default rates and the direction of risk-free rates in the Investment Vehicle's chosen markets, given the Investment Vehicle's predominantly floating rate exposure. The Board is mindful that shareholders expect changes to dividend targets to be made on a sustainable basis, and thus, in the absence of significant and relevant unexpected macroeconomic or geopolitical events, the Company's annual dividend targets should not be changed for at least the next 12 months."

Mr Kirkby added "The Board of Directors also wishes to reconfirm that, in the event that the Investment Vehicle portfolio produces surplus cash income beyond that currently anticipated, an upwards only adjustment will, if appropriate, be made to the Company's fourth quarter 2025 dividends payable in the first quarter of 2026, in a manner similar to that recently announced in respect of the fourth quarter of 2024. There should be no expectation as to the level of any such adjustments or indeed whether such adjustments will arise at all."

The person responsible for arranging for the release of this announcement on behalf of the Company is Sharon A Williams of BNP Paribas S.A., Jersey Branch, Company Secretary.

 

Enquiries:

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPFXAFFSEFA
Date   Source Headline
4th Jun 20264:55 pmRNSIssue of Equity
1st Jun 202612:05 pmRNSNet Asset Value Weekly to 22 May 2026
1st Jun 202610:11 amRNSTotal Voting Rights
29th May 20265:20 pmRNSPUBLICATION OF MONTHLY REPORT
27th May 20264:12 pmRNSIssue of Equity
26th May 20264:51 pmRNSNet Asset Value Month End 30 Apr 2026
21st May 202610:15 amRNSNet Asset Value Weekly to 15 May 2026
15th May 20262:44 pmRNSTotal Voting Rights
14th May 20266:00 pmRNSNet Asset Value Weekly to 08 May 2026
12th May 20262:55 pmRNSNet Asset Value Weekly to 01 May 2026
12th May 20262:51 pmRNSIssue of Equity
7th May 202612:42 pmRNSMARCH 2026 TENDER - PURCHASE OF SHARES
1st May 202610:15 amRNSNet Asset Value Weekly to 24 Apr 2026
1st May 20269:31 amRNSTotal Voting Rights
29th Apr 20263:16 pmRNSPUBLICATION OF MONTHLY REPORT
28th Apr 20262:24 pmRNSDividend Declaration
28th Apr 20261:05 pmRNSResults of 2026 Annual General Meeting
27th Apr 20265:03 pmRNSMarch 2026 Tender Price
27th Apr 20263:44 pmRNSNet Asset Value Month End 31 Mar 2026
24th Apr 20261:25 pmRNSNet Asset Value Weekly to 17 Apr 2026
21st Apr 20264:15 pmRNSMarch 2026 Tender Price
21st Apr 20263:52 pmRNSIssue of Equity
16th Apr 20265:25 pmRNSNet Asset Value Weekly to 10 Apr 2026
10th Apr 20265:40 pmRNSNet Asset Value Weekly to 02 Apr 2026
10th Apr 20261:57 pmRNSNotice of 2026 Annual General Meeting
7th Apr 202610:40 amRNSNet Asset Value Weekly to 27 Mar 2026
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 202612:20 pmRNSNet Asset Value Weekly to 20 Mar 2026
25th Mar 202610:59 amRNSPublication of Monthly Report
24th Mar 20267:00 amRNS2025 Annual Report and Financial Statements
20th Mar 20264:01 pmRNSNet Asset Value Month End 27 Feb 2026
19th Mar 20266:00 pmRNSNet Asset Value Weekly to 13 Mar 2026
17th Mar 20263:42 pmRNSShare Price Movement Update
6th Mar 20264:10 pmRNSNet Asset Value Weekly to 27 Feb 2026
4th Mar 20262:32 pmRNSPUBLICATION OF MONTHLY REPORT
3rd Mar 202611:10 amRNSNet Asset Value Weekly to 20 Feb 2026
2nd Mar 202612:27 pmRNSNet Asset Value Month End 30 Jan 2026
2nd Mar 202610:21 amRNSTotal Voting Rights
26th Feb 20265:13 pmRNSIssue of Equity
20th Feb 20263:25 pmRNSNet Asset Value Weekly to 13 Feb 2026
19th Feb 20263:27 pmRNSIssue of Equity
13th Feb 20266:10 pmRNSNet Asset Value Weekly to 06 Feb 2026
13th Feb 20263:27 pmRNSResult of Tender Offer
12th Feb 20263:48 pmRNSIssue of Equity
6th Feb 202611:40 amRNSNet Asset Value Weekly to 30 Jan 2026
5th Feb 20264:51 pmRNSIssue of Equity
2nd Feb 20265:45 pmRNSNet Asset Value Weekly to 23 Jan 2026
2nd Feb 20264:16 pmRNSDirector/PDMR Shareholding
2nd Feb 202610:39 amRNSTotal Voting Rights
28th Jan 20263:48 pmRNSPublication of Monthly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.